These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3649921)

  • 1. Heparin promotes the inactivation of antithrombin by neutrophil elastase.
    Jordan RE; Kilpatrick J; Nelson RM
    Science; 1987 Aug; 237(4816):777-9. PubMed ID: 3649921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin inactivation by neutrophil elastase requires heparin.
    Jordan RE; Nelson RM; Kilpatrick J; Newgren JO; Esmon PC; Fournel MA
    Am J Med; 1989 Sep; 87(3B):19S-22S. PubMed ID: 2801725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of human antithrombin by neutrophil elastase. Kinetics of the heparin-dependent reaction.
    Jordan RE; Nelson RM; Kilpatrick J; Newgren JO; Esmon PC; Fournel MA
    J Biol Chem; 1989 Jun; 264(18):10493-500. PubMed ID: 2732232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo inactivation of antithrombin III is promoted by heparin during cardiopulmonary bypass.
    Cohen JR; Tenenbaum N; Sarfati I; Tyras D; Graver LM; Weinstein G; Wise L
    J Invest Surg; 1992; 5(1):45-9. PubMed ID: 1576105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of tryptophan modification upon digestion of antithrombin III by elastase.
    Scully MF; Shah N; Ellis V; Kakkar VV
    Thromb Haemost; 1991 Apr; 65(4):351-4. PubMed ID: 2057915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of thrombin- and elastase-modified human antithrombin III.
    Gettins P; Harten B
    Biochemistry; 1988 May; 27(10):3634-9. PubMed ID: 3408716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inactivation of antithrombin III by serum elastase in patients with surgical infections.
    Cohen JR; Sarfati I; Birnbaum E; Benacquista T; Wise L
    Am Surg; 1990 Nov; 56(11):665-7. PubMed ID: 2240857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of human granulocytic elastase on isolated human antithrombin III.
    Jochum M; Lander S; Heimburger N; Fritz H
    Hoppe Seylers Z Physiol Chem; 1981 Feb; 362(2):103-12. PubMed ID: 6783500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial binding sites for heparin. Specificity and role in heparin neutralization.
    Bârzu T; Van Rijn JL; Petitou M; Molho P; Tobelem G; Caen JP
    Biochem J; 1986 Sep; 238(3):847-54. PubMed ID: 2432885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin.
    Machovich R; Bauer PI; Arányi P; Kecskés E; Büki KG; Horváth I
    Biochem J; 1981 Dec; 199(3):521-6. PubMed ID: 6462134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic inactivation of human antithrombin III. Limited proteolysis of the inhibitor by snake venom proteinases in the presence of heparin.
    Kress LF; Catanese J
    Biochim Biophys Acta; 1980 Sep; 615(1):178-86. PubMed ID: 7426659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Size-fractionated heparins have differential effects on human neutrophil function in vitro.
    Lever R; Lo WT; Faraidoun M; Amin V; Brown RA; Gallagher J; Page CP
    Br J Pharmacol; 2007 Jul; 151(6):837-43. PubMed ID: 17533420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antithrombin III activity in relation to multiple administration of various doses of heparin to normal animals].
    Kudriashov BA; Pastorova VE; Liapina LA
    Vopr Med Khim; 1985; 31(3):37-41. PubMed ID: 4024529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human neutrophil elastase alters human alpha-thrombin function: limited proteolysis near the gamma-cleavage site results in decreased fibrinogen clotting and platelet-stimulatory activity.
    Brower MS; Walz DA; Garry KE; Fenton JW
    Blood; 1987 Mar; 69(3):813-9. PubMed ID: 3101765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of a two-step reaction mechanism for the inhibition of heparin-bound neutrophil elastase by alpha 1-proteinase inhibitor.
    Faller B; Cadène M; Bieth JG
    Biochemistry; 1993 Sep; 32(35):9230-5. PubMed ID: 8369290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndecan-4-dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin.
    Kaneider NC; Förster E; Mosheimer B; Sturn DH; Wiedermann CJ
    Thromb Haemost; 2003 Dec; 90(6):1150-7. PubMed ID: 14652650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.
    Griffith MJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5460-4. PubMed ID: 6577437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
    Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
    Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
    Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
    Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.